# FDA Inspection 1228573 - Mitsubishi Tanabe Pharma Factory Ltd. - January 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-factory-ltd/2204d63f-a221-4006-9ae2-d383dc280dd0
Source feed: FDA_Inspections

> FDA Inspection 1228573 for Mitsubishi Tanabe Pharma Factory Ltd. on January 19, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228573
- Company Name: Mitsubishi Tanabe Pharma Factory Ltd.
- Inspection Date: 2024-01-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 950893 - 2015-12-11](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-factory-ltd/93c3c787-b3f0-4361-b7ba-929ce63ce773)
- [FDA Inspection 752836 - 2011-11-03](https://www.keypedia.com/records/fda_inspections/mitsubishi-tanabe-pharma-factory-ltd/88f0b868-14db-4c35-a41c-7fa90352c3a4)

Company: https://www.keypedia.com/companies/mitsubishi-tanabe-pharma-factory-ltd/fdbe886f-d32a-45b9-b675-8b2eefd2de9a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c